FDA voucher program has become vehicle for political interference in drug review decisions, staffers say  statnews.com Exclusive: US FDA taps Merck drugs with blockbuster sales potential for national priority vouchers  Reuters MSD claims two national priority vouchers; report  pharmaphorum US FDA grants priority vouchers to Merck’s cholesterol pill, cancer therapy  1470 & 100.3 WMBD CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor  PharmTech.com